Amutio BF, Sotelo GBL, Ramírez PM, Sánchez DLE

Language: Spanish
References: 14
Page: 127-132
PDF size: 145.61 Kb.

ABSTRACT

Androgenic alopecia (AGA) is the most common non-scarring alopecia whose pathogenesis is related to genetics and androgens, however, other hormones have been involved in the hair follicle cycle, such as vitamin d.
Objective: It is to evaluate the serum levels of vitamin d in patients with aga and to observe if there is a relationship with the severity of the disease, in order to evaluate the role of this hormone in androgenic alopecia.
Methods: prospective, cross-sectional, and descriptive observational study. Thirty-two males clinically and trichoscopic diagnosed with androgenetic alopecia and 37 age-matched healthy controls were recruited, a blood sample was taken from each of both groups to detect the levels of total 25-hydroxyvitamin D.
Results: a greater vitamin D deficiency was found in the control group, when comparing the degree of severity of the disease and the levels of vitamin D, no statistically significant (p = 0.701) was found.
Conclusions: this study does not suggest an important role of the serum level of vitamin D in the pathogenesis of AGA, however it may be the beginning of other research studies including a larger number of patients.

REFERENCES

1. Morales-Miranda AY y Morales-Trujillo L, Alopecias más frecuentesen un centro dermatológico de tercer nivel, Dermatol Rev Mex 2018;62(3):216-20.

2. Vañó Galván S y Jaen Olasolo P, Manual práctico de tricología, Madrid,Medical & Marketing Comunications, 2019, pp. 43-64.

3. Katzer T, Leite Junior A, Beck R y Da Silva C, Physiopathology and currenttreatments of androgenetic alopecia: going beyond androgensand anti-androgens, Dermatol Ther 2019; 32(5):e13059.

4. Seleit I, Bakry OA, Badr E y Hassan EH, Vitamin d receptor gene polymorphismin chronic telogen effluvium; a case-control study, Clin CosmetInvestig Dermatol 2019; 8(12):745-50.

5. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA,Heaney RP y Weaver CM, Evaluation, treatment, and prevention ofvitamin d deficiency: an endocrine society clinical practice guideline, JClin Endocrinol Metab 2011; 96(7):1911-30.

6. Chumlea WC, Rhodes T, Girman CJ, Johnson-Levonas A, Lilly FR, WuR y Guo SS, Family history and risk of hair loss, Dermatology 2004; 209(1):33-9.

7. Sanke S, Samudrala S, Yadav A, Chander R y Goyal R, Study of serumvitamin d levels in men with premature androgenetic alopecia, Int JDermatol 2020; 59(9):1113-6.

8. Carrillo-Vega MF, García-Peña C, Gutiérrez-Robledo LM y Pérez-Zepeda MU, Vitamin d deficiency in older adults and its associatedfactors: a cross-sectional analysis of the Mexican health and agingstudy, Arch Osteoporos 2017; 12(1):8.

9. Daly RM, Gagnon C, Magliano DJ, Dunstan DW, Sikaris KA, ZimmetPZ y Ebeling PR, Prevalence of vitamin D deficiency and its determinantsin Australian adults aged 25 years and older: a national, population-based study, Clin Endocrinol (Oxford) 2012; 77(1):26-35.

10. Martínez-Zavala N, López-Sánchez GN, Vergara-López A, Chávez-Tapia NC, Uribe M y Nuño-Lámbarri N, Vitamin d deficiency in Mexicanshave a high prevalence: a cross-sectional analysis of the patientsfrom the Centro Médico Nacional 20 de Noviembre, Arch Osteoporos2020; 15(1):88.

11. Leary PF, Zamfirova I, Au J y McCracken WH, Effect of latitude onvitamin d levels, Osteopath Assoc 2017; 1:117(7):433-9.

12. Rodríguez-Rodríguez E, Vizuete AA, Sánchez-Rodríguez P, Mora AM,López-Sobaler AM y Ortega RM, Vitamin d deficiency in Spanishpopulation. Importance of egg on nutritional improvement, Nutr Hosp2019; 36(3):3-7.

13. Passeron T, Bouillon R, Callender V, Cestari T, Diepgen TL, Green ACy Young AR, Sunscreen photoprotection and vitamin d status, Br JDermatol 2019; 181(5):916-31.

14. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, EismanJA y Morales-Torres J, Global vitamin d status and determinantsof hypovitaminosis d, Osteoporos Int 2009; 20(11):1807-20.